Investors Fight CBD Co.'s Bid To Ax Suit Over Clinical Trial
By Jack Queen ( June 25, 2020, 6:19 PM EDT) -- Investors accusing CBD drugmaker Zynerba Pharmaceuticals of withholding worrisome clinical trial results from the public have told a Pennsylvania federal court that the company can't beat their proposed class action by relying on its own self-serving interpretations of the data. ...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.